JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Athira Pharma, Inc. (ATHA) Prices 12M Share IPO at $17/Sh
-
Athira Pharma Announces Pricing of Initial Public Offering
-
Athira Pharma Announces Pricing of Initial Public Offering
-
Strongbridge Biopharma (SBBP) Prices 11.11M Share Common Offering at $2.25/Sh
-
UPDATE: JMP Securities Starts Spectrum Pharmaceuticals (SPPI) at Market Outperform
-
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
-
Strongbridge Biopharma (SBBP) Announces Proposed Public Offering of Ordinary Shares
-
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
-
Trillium Closes US$150 Million Public Offering of Common Shares
-
Snowflake (SNOW) IPO More than Doubles on Open; Salesforce, Berkshire Buy IPO Shares
-
Peloton Interactive (PTON) Analyst Day Highlights Diversity of Subscriber Base - JMP Securities
-
Snowflake (SNOW) Prices 28M Class A Share IPO at $120/Sh
-
Snowflake Announces Pricing of Initial Public Offering
-
Adicet (ACET) Announces Completion of Merger with resTORbio (TORC)
-
Adicet Announces Completion of Merger with resTORbio
-
Adicet Announces Completion of Merger with resTORbio
-
Demandbase Expands Leadership Team With New CRO To Reshape The B2B Marketing Landscape
-
Tesla (TSLA) Should Raise Another $15 Billion - JMP Securities
-
Companies with NDRs 09/11
-
Vroom (VRM) Prices 10.8M Share Follow-On Offering at $54.50/Sh
-
Trillium Therapeutics (TRIL) Prices 10M Share Common Offering at $13/Sh
-
Vroom Announces Pricing of Follow-On Offering
-
Trillium Announces Pricing of US$130 Million Public Offering of Common Shares
-
Intra-Cellular Therapies (ITCI) PT Raised to $54 at JMP Securities, Following Earnings
-
Vroom (VRM) Announces Launch of 9M Share Follow-On Offering
-
Vroom Announces Launch of Follow-On Offering
-
JMP Securities Starts Duck Creek Technologies (DCT) at Market Outperform
-
EverQuote Co-founder & CEO Seth Birnbaum to be Interviewed by JMP Securities Analyst Ron Josey on September 8, 2020
-
EverQuote Co-founder & CEO Seth Birnbaum to be Interviewed by JMP Securities Analyst Ron Josey on September 8, 2020
-
Companies with NDRs 09/03
-
Legion Technologies Raises $22 Million Series B as Demand for Next Generation Workforce Management Accelerates
-
SurveyMonkey (SVMK) PT Raised to $30 at JMP Securities Heading into Catalyst Rich Second Half
-
PennantPark Floating Rate Capital (PFLT) PT Raised to $11 at JMP Securities
-
Stifel Hires Konstantinos Aprilakis, M.D. as Managing Director Covering Biotech Sector
-
Snowflake Files Registration Statement for Proposed Initial Public Offering
-
JMP Securities Starts Vertex Inc. (VERX) at Market Outperform
-
Folloze Launches ‘ABM Now’ Solution to Accelerate Time to Revenue for B2B Vendors
-
ZoomInfo Technologies Inc. (ZI) Prices 14.938M Class A Share Upsized Secondary Offering at $37/Sh
-
ZoomInfo Announces Pricing of Secondary Offering of Shares of Class A Common Stock
-
UPDATE: JMP Securities Downgrades Cree (CREE) to Market Perform
-
Concert Pharmaceuticals to Present at The JMP Securities CNS Forum
-
Axial Biotherapeutics to Present at The JMP Securities CNS Forum
-
Trevena to Present at the Virtual JMP Securities CNS Forum
-
Duck Creek Technologies (DCT) IPO Opens 56% Higher
-
Duck Creek Technologies (DCT) Prices 15M Share Common Offering at $27/Sh
-
Duck Creek Technologies Prices Initial Public Offering
-
Duck Creek Technologies Prices Initial Public Offering
-
Minerva Neurosciences to Present at JMP Securities CNS Forum
-
Minerva Neurosciences to Present at JMP Securities CNS Forum
-
Companies with NDRs 08/13

